Allergologia et Immunopathologia

Papers
(The H4-Index of Allergologia et Immunopathologia is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Aeroallergen sensitization in school-age children with allergic rhinitis26
Relationship between montelukast and behavioral problems in preschool children with asthma20
IgE-mediated Anisakis allergy in children19
Study on the antipruritic mechanism of Zanthoxylum bungeanum and Zanthoxylum schinifolium volatile oil on chronic eczema based on H1R and PAR-2 mediated GRPR pathway19
The Buddhasothorn Asthma Severity Score (BASS): A practical screening tool for predicting severe asthma exacerbations for pediatric patients19
Knockdown of CXCL3-inhibited apoptosis and inflammation in lipopolysaccharide-treated BEAS-2B and HPAEC through inactivating MAPKs pathway17
JNJ0966 inhibits PDGF-BB-induced airway smooth muscle cell proliferation and extracellular matrix production by regulating MMP-917
Sevoflurane ameliorates LPS-induced inflammatory injury of HK-2 cells through Sirtuin1/NF-κB pathway16
Quality of life in children with food allergies, psychiatric symptoms, and caregiving burden of their mothers16
From bioinformatics to anti-inflammation and immune regulation: ACT001 in lipopolysaccharide-induced lung injury15
Allergic rhinitis and dental caries: A systematic review15
Activation of the NLRP3 inflammasome by HMGB1 through inhibition of the Nrf2/HO-1 pathway promotes bleomycin-induced pulmonary fibrosis after acute lung injury in rats15
Benefit of educational intervention on Autoinjector Technique for caregivers and paediatric patients with food allergies: A literature review14
lnc-THRIL and miR-125b relate to disease risk, severity, and imbalance of Th1 cells/Th2 cells in allergic rhinitis14
Taxifolin ameliorates sepsis-induced lung capillary leak through inhibiting the JAK/STAT3 pathway14
Combination therapy of specific aeroallergens immunotherapy and omalizumab, in children with severe asthma14
0.041141986846924